This Article Free upon publication Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Braunwald, E. PubMed PubMed Citation Articles by Braunwald, E. Related Collections Congestive Acute coronary syndromes Acute myocardial infarction

(Circulation. 2009;120:170-180.)
© 2009 American Heart Association, Inc.

Special Report

Adventures in Cardiovascular Research

Eugene Braunwald, MD

From the Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, and Department of Medicine, Harvard Medical School, Boston, Mass.

Correspondence to Eugene Braunwald, MD, Thrombolysis in Myocardial Infarction Study Group, 350 Longwood Ave, Boston, MA 02115. E-mail ebraunwald{at}partners.org

This article, derived from an invited Distinguished Scientist lecture presented at the American Heart Association Scientific Sessions in 2007, reviews 4 themes (adventures) in clinical cardiovascular research carried out over a period of 58 years. It begins with the author’s introduction to cardiovascular hemodynamics during a medical school elective in 1951. The 4 adventures include valvular heart disease, hypertrophic cardiomyopathy, heart failure (HF), and myocardial ischemia. In each of these adventures, the author describes briefly what was known when he entered each field, followed by the author’s contribution to the field (the adventure), and ends with comments about the current status of the field. Of particular interest are the changes in the technologies used in clinical cardiovascular research over the past half century, commencing with pressure tracings in left heart chambers with the use of needle puncture in the operating room to genetic technologies designed to understand differences between drugs that inhibit platelet activation. The article ends with some general comments on conducting research and the rewards that can come with this activity.

Key Words: cardiomyopathy • heart diseases • heart failure • infarction • ischemia